Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced today that it has closed a $40 million (circa £30 million) investment round. The round was led by Sofinnova Partners (Paris, France) and Redmile Group (San Francisco, USA) co-investing on equal terms.
Sphere Fluidics Limited
Sphere Fluidics is commercialising novel products and R&D services in the area of single cell analysis and characterisation.
Telephone: +44 (0)1223 628890
The McClintock Building, Suite 7, Ground Floor Granta Park, Great Abington Cambridge
Post Code: CB21 6GP
Country: United Kingdom
Membership Type: Corporate 21-50